Sygnis Pharma AG Konv - Stockquote Aktien & Wertpapierkurse
powered by GOYAX

Key Figures

Consolidated key figures of SYGNIS Pharma AG (IFRS)
In € thousand (except for share figures and employees)
2010/11 2009/10 2008/09 2007/08
Statement of comprehensive income (ending March 31) (ending March 31) (ending March 31) (ending March 31)
Revenues 213 251 396 519
Research and development expenses 10,545 6,390 8,076 5,291
Administrative expenses 1,670 1,766 1,907 1,433
EBIT (12,772) (8,932) (10,799) (7,248)
Net loss for the year (12,373) (10,336) (10,339) (6,312)
Selected balance sheet data
Non-current assets (24,689) 31,890 31,106 25,052
thereof goodwill 3,332 3,332 3,332 2,361
thereof other intangible assets 20,783 21,914 22,245 17,819
thereof available-for-sale financial assets 159 6,017 4,797 4,136
Current assets 7,571 11,038 19,076 16,482
thereof available-for-sale financial assets 5,365 824 710 5,396
thereof cash and cash equivalents 1,473 8,830 16,946 10,101
Shareholders' equity 17,692 30,147 36,170 29,459
Non-current financial liabilities 8,000 8,000 8,000 8,000
Total assets / total liabilities & equity 32,260 42,928 50,182 41,534
Capital ratio in % 54.8 70.2 72.1 70.9
Statement of cash flows
Net cash used in operating activities (8,263) (8,733) (9,335) (5,303)
Net cash used in investing activities 921 599 (2,018) (522)
Net cash provided from financing activities 0 0 18,106 0
Other
Employees as of March 31 25 41 47 43
Share*
Earnings per share (basic and diluted, in €) (0.90) (0.75) (0.31) (0.23)
Equity per share (in €) 1.29 2.19 1.08 1.06
Average number of shares outstanding 13,752,881 13,752,881 33,436,971 27,677,710
Share price (in €) 2.49 3.15 1.23 1.39
Market capitalisation (in € m) 34.2 43.3 50.7 38.5

* In the 2010/2011 fiscal year a capital reduction and a consolidation of shares at a ratio of 3:1 were concluded. In order to improve the comparability the share figures as of 31 March 2010 have been adjusted retroactively.


You are here : SYGNIS Pharma AG > Investor Relations > Key Figures
Imprint Disclaimer © 2012 SYGNIS AG